ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-218 | Pharmaceuticals
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Onychomycosis (Tinea Unguium) Drug Industry Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET
7.1 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Letai
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Galderma
16.3 Johnson & Johnson
16.4 Valeant Pharma
16.5 Pfizer
16.6 Xiuzheng Pharmaceutical
16.7 GSK
16.8 Kaken Pharmaceutical
16.9 Novartis
16.10 Qilu Pharmaceutical
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :External
Oral
Market by Application :
Age above 50
Age 18-50
Age under 18
Companies
Letai
Galderma
Johnson & Johnson
Valeant Pharma
Pfizer
Xiuzheng Pharmaceutical
GSK
Kaken Pharmaceutical
Novartis
Qilu Pharmaceutical
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.